Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 32 | 2021 | 395 | 7.580 |
Why?
|
Lens Implantation, Intraocular | 27 | 2021 | 195 | 7.190 |
Why?
|
Cataract Extraction | 26 | 2021 | 448 | 6.820 |
Why?
|
Cataract | 32 | 2021 | 798 | 5.850 |
Why?
|
Aphakia, Postcataract | 16 | 2021 | 46 | 4.850 |
Why?
|
Lenses, Intraocular | 14 | 2021 | 125 | 4.620 |
Why?
|
Ophthalmology | 13 | 2021 | 444 | 2.270 |
Why?
|
Retinal Neoplasms | 6 | 2015 | 141 | 2.200 |
Why?
|
Strabismus | 9 | 2021 | 237 | 1.950 |
Why?
|
Retinoblastoma | 5 | 2015 | 315 | 1.930 |
Why?
|
Refraction, Ocular | 6 | 2020 | 171 | 1.850 |
Why?
|
Glaucoma | 7 | 2021 | 909 | 1.780 |
Why?
|
Optics and Photonics | 4 | 2014 | 319 | 1.710 |
Why?
|
Visual Acuity | 22 | 2021 | 2513 | 1.640 |
Why?
|
Academies and Institutes | 11 | 2021 | 303 | 1.630 |
Why?
|
Glaucoma Drainage Implants | 2 | 2021 | 103 | 1.590 |
Why?
|
Aphakia | 2 | 2019 | 9 | 1.550 |
Why?
|
Contact Lenses | 4 | 2019 | 153 | 1.500 |
Why?
|
Pseudophakia | 7 | 2020 | 61 | 1.320 |
Why?
|
Intraocular Pressure | 8 | 2021 | 1164 | 1.110 |
Why?
|
Refractive Errors | 5 | 2017 | 127 | 1.070 |
Why?
|
Infant, Newborn | 48 | 2021 | 23953 | 0.980 |
Why?
|
Hydrophthalmos | 1 | 2021 | 10 | 0.920 |
Why?
|
Lens Capsule, Crystalline | 1 | 2019 | 43 | 0.790 |
Why?
|
Eye Diseases | 4 | 2016 | 655 | 0.790 |
Why?
|
Myopia | 2 | 2018 | 235 | 0.780 |
Why?
|
Orthokeratologic Procedures | 1 | 2018 | 8 | 0.770 |
Why?
|
Infant | 43 | 2021 | 33918 | 0.770 |
Why?
|
Amblyopia | 2 | 2019 | 122 | 0.770 |
Why?
|
Technology Assessment, Biomedical | 7 | 2021 | 296 | 0.760 |
Why?
|
Lens, Crystalline | 3 | 2020 | 420 | 0.730 |
Why?
|
Angiogenesis Inhibitors | 4 | 2020 | 2094 | 0.710 |
Why?
|
Vision, Low | 1 | 2020 | 155 | 0.710 |
Why?
|
Infant, Premature, Diseases | 2 | 2021 | 711 | 0.710 |
Why?
|
Child, Preschool | 35 | 2021 | 41159 | 0.700 |
Why?
|
Eye Injuries | 1 | 2020 | 218 | 0.690 |
Why?
|
Eyeglasses | 1 | 2019 | 136 | 0.690 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2019 | 3429 | 0.690 |
Why?
|
Optic Disk | 1 | 2021 | 391 | 0.670 |
Why?
|
Retinal Diseases | 2 | 2021 | 681 | 0.650 |
Why?
|
Ectopia Lentis | 2 | 2013 | 15 | 0.650 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2020 | 660 | 0.630 |
Why?
|
Neonatal Screening | 4 | 2020 | 558 | 0.620 |
Why?
|
Dacryocystorhinostomy | 3 | 2008 | 74 | 0.610 |
Why?
|
Gestational Age | 18 | 2021 | 3308 | 0.610 |
Why?
|
Melphalan | 2 | 2014 | 364 | 0.590 |
Why?
|
Neuroectodermal Tumors, Primitive | 2 | 2014 | 130 | 0.570 |
Why?
|
Child | 31 | 2021 | 71361 | 0.570 |
Why?
|
Pupil Disorders | 1 | 2014 | 26 | 0.570 |
Why?
|
Photography | 2 | 2010 | 526 | 0.570 |
Why?
|
Nasolacrimal Duct | 2 | 2008 | 70 | 0.570 |
Why?
|
Infant, Premature | 13 | 2021 | 2034 | 0.560 |
Why?
|
Infusions, Intra-Arterial | 1 | 2014 | 249 | 0.550 |
Why?
|
Corneal Endothelial Cell Loss | 1 | 2013 | 20 | 0.520 |
Why?
|
Glaucoma, Open-Angle | 1 | 2019 | 640 | 0.510 |
Why?
|
Retinal Vessels | 2 | 2016 | 738 | 0.490 |
Why?
|
Nystagmus, Pathologic | 1 | 2012 | 96 | 0.490 |
Why?
|
gamma-Crystallins | 1 | 2011 | 11 | 0.480 |
Why?
|
Hyperopia | 1 | 2012 | 42 | 0.480 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2014 | 634 | 0.470 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2016 | 257 | 0.470 |
Why?
|
Humans | 101 | 2021 | 686663 | 0.460 |
Why?
|
Ophthalmologic Surgical Procedures | 3 | 2021 | 320 | 0.460 |
Why?
|
Laser Coagulation | 3 | 2010 | 299 | 0.460 |
Why?
|
Weight Gain | 4 | 2021 | 2168 | 0.450 |
Why?
|
Postoperative Complications | 9 | 2021 | 15083 | 0.450 |
Why?
|
Endothelium, Corneal | 1 | 2013 | 164 | 0.440 |
Why?
|
Phacoemulsification | 1 | 2013 | 155 | 0.440 |
Why?
|
Propoxycaine | 1 | 2010 | 7 | 0.430 |
Why?
|
Benchmarking | 1 | 2016 | 880 | 0.420 |
Why?
|
Intravitreal Injections | 4 | 2020 | 299 | 0.420 |
Why?
|
Lasers, Semiconductor | 1 | 2010 | 48 | 0.410 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2013 | 365 | 0.410 |
Why?
|
Vision Disorders | 3 | 2020 | 978 | 0.400 |
Why?
|
Eye Neoplasms | 1 | 2012 | 327 | 0.400 |
Why?
|
Mydriatics | 3 | 2020 | 55 | 0.390 |
Why?
|
Anterior Eye Segment | 1 | 2010 | 149 | 0.380 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2013 | 656 | 0.370 |
Why?
|
Retinoscopy | 3 | 2020 | 30 | 0.370 |
Why?
|
Infant, Very Low Birth Weight | 7 | 2016 | 422 | 0.370 |
Why?
|
Mucocele | 1 | 2008 | 52 | 0.370 |
Why?
|
Schools | 1 | 2017 | 1303 | 0.370 |
Why?
|
Optic Nerve Neoplasms | 1 | 2008 | 53 | 0.360 |
Why?
|
Hemangioma | 1 | 2013 | 769 | 0.350 |
Why?
|
Fluprednisolone | 2 | 2016 | 7 | 0.340 |
Why?
|
Atropine | 2 | 2017 | 255 | 0.330 |
Why?
|
Birth Weight | 4 | 2021 | 1897 | 0.320 |
Why?
|
Endoscopy | 3 | 2008 | 1688 | 0.320 |
Why?
|
Communication | 1 | 2020 | 3237 | 0.310 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1836 | 0.300 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3340 | 0.300 |
Why?
|
Prednisolone | 2 | 2016 | 335 | 0.300 |
Why?
|
Prosthesis Implantation | 2 | 2021 | 645 | 0.290 |
Why?
|
Suture Techniques | 2 | 2021 | 791 | 0.290 |
Why?
|
Oxygen | 3 | 2021 | 4014 | 0.280 |
Why?
|
Retrospective Studies | 22 | 2021 | 67320 | 0.280 |
Why?
|
Neurofibromatosis 1 | 1 | 2008 | 499 | 0.270 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2006 | 362 | 0.260 |
Why?
|
Follow-Up Studies | 14 | 2021 | 39737 | 0.260 |
Why?
|
Soft Tissue Neoplasms | 1 | 2012 | 1310 | 0.250 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2020 | 734 | 0.240 |
Why?
|
Treatment Outcome | 16 | 2021 | 60991 | 0.240 |
Why?
|
Female | 49 | 2021 | 375459 | 0.240 |
Why?
|
Vision, Binocular | 2 | 2021 | 179 | 0.230 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3454 | 0.230 |
Why?
|
Lacrimal Duct Obstruction | 3 | 2008 | 50 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2019 | 2017 | 0.230 |
Why?
|
Mutation, Missense | 1 | 2011 | 2570 | 0.230 |
Why?
|
Wolfram Syndrome | 1 | 2020 | 17 | 0.220 |
Why?
|
Risk Factors | 15 | 2021 | 69278 | 0.220 |
Why?
|
Male | 46 | 2021 | 352465 | 0.210 |
Why?
|
Ophthalmoscopy | 2 | 2014 | 179 | 0.210 |
Why?
|
Eye Diseases, Hereditary | 1 | 2021 | 113 | 0.200 |
Why?
|
Artificial Intelligence | 2 | 2021 | 1424 | 0.200 |
Why?
|
Oxygen Consumption | 1 | 2006 | 1955 | 0.200 |
Why?
|
Pain Measurement | 1 | 2010 | 3402 | 0.190 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2001 | 225 | 0.190 |
Why?
|
Angiogenic Proteins | 1 | 2019 | 107 | 0.190 |
Why?
|
Lens Subluxation | 1 | 2018 | 17 | 0.190 |
Why?
|
Placental Insufficiency | 1 | 2019 | 49 | 0.190 |
Why?
|
Nerve Growth Factors | 2 | 2019 | 611 | 0.190 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2019 | 127 | 0.180 |
Why?
|
Prosthesis Design | 2 | 2020 | 2231 | 0.180 |
Why?
|
Biometry | 2 | 2013 | 535 | 0.180 |
Why?
|
Vitrectomy | 2 | 2018 | 352 | 0.180 |
Why?
|
Colorado | 1 | 2018 | 161 | 0.180 |
Why?
|
Hemangioma, Capillary | 1 | 2018 | 64 | 0.180 |
Why?
|
Oculomotor Muscles | 1 | 2021 | 311 | 0.180 |
Why?
|
Iris | 1 | 2019 | 233 | 0.180 |
Why?
|
Infant, Extremely Low Birth Weight | 3 | 2019 | 94 | 0.180 |
Why?
|
Sclera | 1 | 2019 | 200 | 0.170 |
Why?
|
Aptamers, Nucleotide | 1 | 2019 | 166 | 0.170 |
Why?
|
Eye | 2 | 2013 | 726 | 0.170 |
Why?
|
Telemedicine | 3 | 2020 | 2270 | 0.170 |
Why?
|
Placenta | 2 | 2019 | 1353 | 0.170 |
Why?
|
Eyelid Neoplasms | 1 | 2018 | 94 | 0.170 |
Why?
|
Ophthalmic Solutions | 3 | 2016 | 311 | 0.170 |
Why?
|
Tomography, Optical Coherence | 2 | 2021 | 2576 | 0.160 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2016 | 9 | 0.160 |
Why?
|
Marfan Syndrome | 1 | 2018 | 229 | 0.160 |
Why?
|
Retinal Vein Occlusion | 1 | 1997 | 113 | 0.160 |
Why?
|
Propranolol | 1 | 2018 | 528 | 0.160 |
Why?
|
Epinephrine | 1 | 2020 | 804 | 0.160 |
Why?
|
Sensory Deprivation | 1 | 2016 | 106 | 0.160 |
Why?
|
Orbital Neoplasms | 1 | 2018 | 249 | 0.150 |
Why?
|
Uveitis, Anterior | 1 | 2016 | 105 | 0.150 |
Why?
|
Blepharoptosis | 1 | 2016 | 139 | 0.150 |
Why?
|
Inflammation | 4 | 2019 | 9617 | 0.140 |
Why?
|
Blue Toe Syndrome | 1 | 2014 | 5 | 0.140 |
Why?
|
Fetal Growth Retardation | 2 | 2019 | 541 | 0.140 |
Why?
|
Genes, Retinoblastoma | 1 | 2015 | 141 | 0.140 |
Why?
|
United States | 13 | 2021 | 65579 | 0.140 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5354 | 0.140 |
Why?
|
Disabled Children | 1 | 2017 | 255 | 0.140 |
Why?
|
Nigeria | 1 | 2017 | 664 | 0.140 |
Why?
|
Eye Enucleation | 1 | 2014 | 133 | 0.140 |
Why?
|
CpG Islands | 1 | 2019 | 1151 | 0.140 |
Why?
|
Glioma | 1 | 2008 | 3110 | 0.140 |
Why?
|
Ophthalmic Artery | 1 | 2014 | 65 | 0.140 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 216 | 0.130 |
Why?
|
Emmetropia | 1 | 2013 | 7 | 0.130 |
Why?
|
Ciliary Body | 1 | 2014 | 165 | 0.130 |
Why?
|
Injections, Intra-Arterial | 1 | 2013 | 205 | 0.130 |
Why?
|
Infant, Low Birth Weight | 1 | 2018 | 823 | 0.130 |
Why?
|
Axial Length, Eye | 1 | 2013 | 30 | 0.130 |
Why?
|
Eye Proteins | 1 | 2017 | 703 | 0.130 |
Why?
|
Mitochondrial Diseases | 1 | 2016 | 303 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2019 | 1799 | 0.130 |
Why?
|
Astigmatism | 1 | 2013 | 70 | 0.120 |
Why?
|
Eyelid Diseases | 1 | 2014 | 158 | 0.120 |
Why?
|
Eye Abnormalities | 1 | 2014 | 230 | 0.120 |
Why?
|
Retinal Detachment | 1 | 2016 | 385 | 0.120 |
Why?
|
Retinal Vein | 2 | 2005 | 48 | 0.120 |
Why?
|
Refractometry | 1 | 2012 | 54 | 0.120 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1250 | 0.120 |
Why?
|
Adolescent | 9 | 2020 | 84957 | 0.120 |
Why?
|
Cell Shape | 1 | 2013 | 376 | 0.120 |
Why?
|
Topotecan | 1 | 2012 | 135 | 0.120 |
Why?
|
Uveal Neoplasms | 1 | 2014 | 301 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2020 | 19308 | 0.120 |
Why?
|
Tuberous Sclerosis | 1 | 2020 | 995 | 0.120 |
Why?
|
Endophthalmitis | 1 | 2014 | 251 | 0.120 |
Why?
|
Prospective Studies | 9 | 2021 | 49071 | 0.110 |
Why?
|
Arthritis | 1 | 2016 | 637 | 0.110 |
Why?
|
Odds Ratio | 4 | 2019 | 10108 | 0.110 |
Why?
|
Algorithms | 5 | 2021 | 13500 | 0.110 |
Why?
|
Chorioamnionitis | 1 | 2011 | 150 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13898 | 0.110 |
Why?
|
Epidermolysis Bullosa Dystrophica | 1 | 2010 | 18 | 0.110 |
Why?
|
Hyphema | 1 | 2010 | 29 | 0.110 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2011 | 341 | 0.100 |
Why?
|
Catheterization, Peripheral | 1 | 2014 | 353 | 0.100 |
Why?
|
Fixation, Ocular | 1 | 2011 | 232 | 0.100 |
Why?
|
Databases, Factual | 4 | 2019 | 7865 | 0.100 |
Why?
|
Orbital Cellulitis | 1 | 2010 | 28 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 42271 | 0.100 |
Why?
|
Vincristine | 1 | 2012 | 1032 | 0.100 |
Why?
|
Logistic Models | 3 | 2015 | 13807 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3983 | 0.100 |
Why?
|
Retinal Neovascularization | 1 | 2012 | 263 | 0.100 |
Why?
|
Incidence | 4 | 2021 | 20496 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.100 |
Why?
|
Skin Ulcer | 1 | 2010 | 131 | 0.100 |
Why?
|
Ocular Hypertension | 1 | 2010 | 180 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1446 | 0.090 |
Why?
|
Disease Progression | 3 | 2018 | 13204 | 0.090 |
Why?
|
Cell Count | 1 | 2013 | 1974 | 0.090 |
Why?
|
Mutation | 4 | 2020 | 28848 | 0.090 |
Why?
|
Genes, Dominant | 1 | 2011 | 939 | 0.090 |
Why?
|
Corneal Diseases | 1 | 2014 | 549 | 0.090 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1747 | 0.090 |
Why?
|
Microscopy | 1 | 2013 | 853 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2016 | 1024 | 0.090 |
Why?
|
False Positive Reactions | 2 | 2012 | 1030 | 0.090 |
Why?
|
Remote Consultation | 1 | 2010 | 251 | 0.090 |
Why?
|
Massachusetts | 1 | 2021 | 8920 | 0.090 |
Why?
|
Eye Infections, Bacterial | 1 | 2010 | 232 | 0.080 |
Why?
|
Pregnancy | 7 | 2019 | 25703 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2012 | 1939 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2016 | 2100 | 0.080 |
Why?
|
Cellulitis | 1 | 2008 | 204 | 0.080 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2207 | 0.080 |
Why?
|
Carbon Dioxide | 1 | 2010 | 1162 | 0.080 |
Why?
|
Face | 1 | 2012 | 963 | 0.080 |
Why?
|
Genetic Linkage | 1 | 2011 | 2600 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1943 | 0.070 |
Why?
|
DNA Methylation | 1 | 2019 | 3987 | 0.070 |
Why?
|
Retinal Artery | 1 | 2005 | 115 | 0.070 |
Why?
|
Doxorubicin | 1 | 2012 | 2249 | 0.070 |
Why?
|
Risk Assessment | 3 | 2021 | 23739 | 0.070 |
Why?
|
Brain Diseases | 1 | 2014 | 1545 | 0.070 |
Why?
|
Pedigree | 2 | 2011 | 4792 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2010 | 1950 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15407 | 0.070 |
Why?
|
Heterozygote | 1 | 2011 | 2787 | 0.070 |
Why?
|
Nutritional Status | 1 | 2013 | 1554 | 0.070 |
Why?
|
Craniofacial Abnormalities | 1 | 2007 | 316 | 0.070 |
Why?
|
Double-Blind Method | 3 | 2016 | 11866 | 0.070 |
Why?
|
Body Weight | 1 | 2015 | 4804 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 4958 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3797 | 0.060 |
Why?
|
Oximetry | 1 | 2006 | 448 | 0.060 |
Why?
|
Child Development | 1 | 2015 | 2279 | 0.060 |
Why?
|
Anesthetics, Local | 1 | 2010 | 993 | 0.060 |
Why?
|
Pediatrics | 1 | 2018 | 3572 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2015 | 2400 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 8262 | 0.060 |
Why?
|
Risk | 1 | 2015 | 9915 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2010 | 1567 | 0.060 |
Why?
|
Prevalence | 2 | 2011 | 14744 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4415 | 0.060 |
Why?
|
Pandemics | 1 | 2021 | 5859 | 0.060 |
Why?
|
Equipment Design | 1 | 2010 | 3653 | 0.060 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2020 | 669 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 1997 | 4132 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2011 | 1594 | 0.060 |
Why?
|
Regression Analysis | 1 | 2011 | 6669 | 0.050 |
Why?
|
Surgical Flaps | 1 | 2010 | 1630 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 1 | 2008 | 1531 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 15075 | 0.050 |
Why?
|
Syndrome | 1 | 2007 | 3178 | 0.050 |
Why?
|
Treatment Failure | 1 | 2007 | 2697 | 0.050 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 723 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2011 | 1910 | 0.050 |
Why?
|
Dark Adaptation | 1 | 2001 | 234 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2017 | 4928 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11265 | 0.050 |
Why?
|
Sensory Thresholds | 1 | 2001 | 410 | 0.050 |
Why?
|
Crystallins | 1 | 1999 | 78 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2014 | 33186 | 0.050 |
Why?
|
Vision Tests | 1 | 2019 | 161 | 0.050 |
Why?
|
Sutures | 1 | 2021 | 294 | 0.050 |
Why?
|
Base Sequence | 1 | 2011 | 13729 | 0.050 |
Why?
|
Electroretinography | 1 | 2001 | 572 | 0.050 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 340 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13603 | 0.050 |
Why?
|
Models, Biological | 1 | 2016 | 10102 | 0.040 |
Why?
|
Glaucoma, Neovascular | 1 | 1997 | 32 | 0.040 |
Why?
|
Acute Disease | 2 | 2016 | 7202 | 0.040 |
Why?
|
Anterior Chamber | 1 | 2018 | 205 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2020 | 673 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1999 | 813 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 19328 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 21640 | 0.040 |
Why?
|
Cognition | 1 | 2014 | 5582 | 0.040 |
Why?
|
Fundus Oculi | 1 | 1997 | 465 | 0.040 |
Why?
|
Age of Onset | 2 | 2020 | 3373 | 0.040 |
Why?
|
Retina | 2 | 2020 | 2627 | 0.040 |
Why?
|
Safety | 1 | 2001 | 1247 | 0.040 |
Why?
|
Depth Perception | 1 | 2016 | 93 | 0.040 |
Why?
|
Young Adult | 2 | 2013 | 56052 | 0.040 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1281 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 11616 | 0.040 |
Why?
|
Pain | 1 | 2010 | 4295 | 0.040 |
Why?
|
Coloboma | 1 | 2014 | 56 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 730 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 199 | 0.030 |
Why?
|
S100 Proteins | 1 | 2014 | 275 | 0.030 |
Why?
|
ROC Curve | 2 | 2016 | 3583 | 0.030 |
Why?
|
Adult | 6 | 2021 | 211400 | 0.030 |
Why?
|
Registries | 2 | 2020 | 8033 | 0.030 |
Why?
|
Blood Proteins | 1 | 2019 | 1135 | 0.030 |
Why?
|
Cryotherapy | 1 | 2014 | 168 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 529 | 0.030 |
Why?
|
Life Tables | 1 | 2013 | 377 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2014 | 522 | 0.030 |
Why?
|
Point Mutation | 1 | 1999 | 1707 | 0.030 |
Why?
|
Keratins | 1 | 2014 | 557 | 0.030 |
Why?
|
Choroid | 1 | 2014 | 318 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1318 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15296 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1234 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2018 | 16227 | 0.030 |
Why?
|
Reoperation | 1 | 2001 | 4175 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1928 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11115 | 0.030 |
Why?
|
Canada | 1 | 2015 | 1905 | 0.030 |
Why?
|
Skin Care | 1 | 2010 | 57 | 0.030 |
Why?
|
Mucin-1 | 1 | 2014 | 545 | 0.020 |
Why?
|
Eyelids | 1 | 2010 | 238 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2010 | 295 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 28923 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 1997 | 2006 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1794 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2009 | 488 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20409 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2009 | 551 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2729 | 0.020 |
Why?
|
Erythropoietin | 1 | 2009 | 712 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2531 | 0.020 |
Why?
|
Trans-Activators | 1 | 2014 | 3150 | 0.020 |
Why?
|
Cytokines | 1 | 2017 | 7147 | 0.010 |
Why?
|
Area Under Curve | 1 | 2005 | 1738 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4716 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2009 | 1263 | 0.010 |
Why?
|
Nuclear Family | 1 | 1999 | 325 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12734 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13444 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 4017 | 0.010 |
Why?
|
Exons | 1 | 1999 | 2519 | 0.010 |
Why?
|
Diet | 1 | 2009 | 7351 | 0.010 |
Why?
|
Animals | 3 | 2009 | 170849 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6464 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 8926 | 0.010 |
Why?
|
Models, Molecular | 1 | 1999 | 5778 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4436 | 0.010 |
Why?
|
Brain | 1 | 2014 | 24202 | 0.010 |
Why?
|
Genotype | 1 | 1999 | 13073 | 0.000 |
Why?
|